Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 10945038)

Published in Springer Semin Immunopathol on January 01, 1999

Authors

M C Le Bousse-Kerdilès1, M C Martyré

Author Affiliations

1: INSERM U268, Hôpital Paul Brousse, Villejuif, France.

Articles by these authors

Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol (1999) 0.96

Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood (1996) 0.92

[Extraction and purification of tumoral neo-antigens obtained from splenic cells and serum of mice with Charolotte Friend's leukemia]. Rev Fr Etud Clin Biol (1968) 0.81

Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis. Pathol Biol (Paris) (2001) 0.79

p95(vav) associates with the type I interferon (IFN) receptor and contributes to the antiproliferative effect of IFN-alpha in megakaryocytic cell lines. Oncogene (2000) 0.78

Characterization and partial purification of normal and tumor associated transplantation antigens of Rauscher leukemia cells. Eur J Cancer (1973) 0.75

[New data on hydrosoluble graft antigens from BP-8 tumoral murine cells]. Rev Fr Etud Clin Biol (1969) 0.75

Altered transcription of the stem cell leukemia gene in myelofibrosis with myeloid metaplasia. Leukemia (2003) 0.75

Conditioning of allogeneic mice with crude and purified H-2 extracts, alone and combined with cyclophosphamide, for skin graft prolongation. Transplant Proc (1971) 0.75

Lack of interferon-alpha-induced tyrosine phosphorylation of Vav proto-oncogene in patients with myelofibrosis with myeloid metaplasia. Br J Haematol (2000) 0.75

Conditioning of allogeneic skin grafts recipients with crude and water soluble H-2 antigens derived from BP-8 murine tumor cell membranes. Rev Eur Etud Clin Biol (1970) 0.75

Prolongation of skin graft survival in mice by pretreatment with H-2 antigen and cyclophosphamide. Rev Eur Etud Clin Biol (1970) 0.75

Specific immunotherapy of acute lymphoid leukemia patients by REH cell line. Recent Results Cancer Res (1980) 0.75

Short- and long-term synergistic effects of human tumor necrosis factor and interferon-gamma on A549 human lung cancer cells maintained in three-dimensional culture. Anticancer Res (1990) 0.75

Contribution to the study of the solubilization and purification of H-2 antigens obtained from BP-8 murine cell membranes. Rev Eur Etud Clin Biol (1970) 0.75